title: Growth rate suppression of cultured mammalian cells enhances protein productivity.
abstract: Suppression of proliferation of cells which contain stable or stabilized mRNA coded for a protein to be produced, a partial mimic of cell differentiation, was examined for enhancing protein production by cultured mammalian cells. Hybridoma 2E3 cells which were adapted to be interleukin-6 sensitivity growth-suppressed accumulated the mRNA of IgG1 which is reported stable, and IgG1 production rate increased as a result when their growth was suppressed with interleukin-6. A myeloma cell line was similarly adapted; the obtained myeloma cells can be used as host cells for enhancing production of exogenous proteins by suppressing growth with interleukin-6. Temperature-sensitively growth-suppressible mutants of mouse mammary carcinoma FM3A were transfected with cDNA of IgM lambda 1 chain and cultured at nonpermissive temperature to enhance production of lambda 1. Addition of various growth-suppressive reagents to culture medium was studied for finding methods suitable for suppressing growth while maintaining high cell viability. Caffeine yielded the best results among these reagents. Deprivation of various growth-supporting components in culture medium was also tested; simultaneous deprivation of insulin and transferrin viably suppressed growth of hybridoma 2E3 cells, resulting in enhanced antibody productivity.
authors.affiliation: Department of Chemistry and Biotechnology, Faculty of Engineering, University of Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: S
authors.initials: S
authors.lastname: Tereda
authors.forename: H
authors.initials: H
authors.lastname: Ueda
authors.forename: F
authors.initials: F
authors.lastname: Makishima
authors.forename: E
authors.initials: E
authors.lastname: Suzuki
mesh_terms: D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002454:Cell Differentiation; D002455:Cell Division / Q000187:drug effects / Q000502:physiology*; D018076:DNA, Complementary; D006801:Humans; D006825:Hybridomas; D007074:Immunoglobulin G / Q000096:biosynthesis* / Q000145:classification; D007075:Immunoglobulin M / Q000096:biosynthesis*; D007146:Immunoglobulin lambda-Chains / Q000096:biosynthesis; D015850:Interleukin-6 / Q000494:pharmacology; D007700:Kinetics; D008322:Mammals; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D012333:RNA, Messenger / Q000378:metabolism; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000494:pharmacology; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D018076:DNA, Complementary; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007146:Immunoglobulin lambda-Chains; D015850:Interleukin-6; D012333:RNA, Messenger; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; D002110:Caffeine